Fecal Microbiota Transplants Annually and Their Positive Clinical Impact

4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

INTRODUCTION: Although fecal microbiota transplantation (FMT) is a recommended, clinically efficacious, and cost-effective treatment for recurrent Clostridioides difficile infection (CDI), the scale of FMT use in the United States is unknown. METHODS: We developed a population-level CDI model. RESULTS: We estimated that 48,000 FMTs could be performed annually, preventing 32,000 CDI recurrences. DISCUSSION: Improving access to FMT could lead to tens of thousands fewer C. difficile episodes per year.

Cite

CITATION STYLE

APA

Mamoon, L., & Olesen, S. W. (2020). Fecal Microbiota Transplants Annually and Their Positive Clinical Impact. Clinical and Translational Gastroenterology, 11(11), e00247. https://doi.org/10.14309/ctg.0000000000000247

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free